Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:103-109
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kugiyama, K.
Right arrow Articles by Yasue, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kugiyama, K.
Right arrow Articles by Yasue, H.

CLINICAL STUDIES

Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina

Kiyotaka Kugiyama, MDa, Takeshi Motoyama, MDa, Osamu Hirashima, MDa, Masamichi Ohgushi, MDa, Hirofumi Soejima, MDa, Kenji Misumi, MDa, Hiroaki Kawano, MDa, Yuji Miyao, MDa, Michihiro Yoshimura, MDa, Hisao Ogawa, MDa, Toshiyuki Matsumura, MDa, Seigo Sugiyama, MDa and Hirofumi Yasue, MDa

a Division of Cardiology, Kumamoto University School of Medicine, Kumamoto, Japan

Manuscript received December 9, 1997; revised manuscript received March 16, 1998, accepted March 20, 1998.

Address for correspondence: Dr. Kiyotaka Kugiyama, Division of Cardiology, Kumamoto University School of Medicine, Honjo 1-1-1, Kumamoto City, Japan 860-8556
kiyo{at}gpo.kumamoto-u.ac.jp

Objectives. This study sought to examine effect of vitamin C, an antioxidant, on the abnormal vasomotor reactivity in spasm coronary arteries.

Background. Oxygen free radicals generated in the arterial walls have been shown to cause endothelial vasomotor dysfunction.

Methods. Responses of the epicardial arterial diameters of the left coronary arteries to the intracoronary infusion of acetylcholine (ACh) (10 and 50 µg/min) were measured by quantitative coronary angiography before and during combined intracoronary infusion of vitamin C (10 mg/min) or saline as a placebo in 32 patients with coronary spastic angina and in 34 control subjects.

Results. Vitamin C infusion suppressed the constrictor response of the epicardial diameter to ACh in spasm coronary arteries but had no significant effect in the control coronary arteries (percent change in distal diameter in response to 10 µg/min of ACh [constriction (–), dilation (+), mean ± SEM] before vitamin C: –8.2 ± 2.9% in spasm arteries, +8.4 ± 2.9%* in control arteries; during vitamin C: +0.2 ± 3.8%* in spasm arteries, +7.2 ± 1.3%* in control arteries [*p < 0.01 vs. spasm arteries before vitamin C]). The coronary sinus–arterial difference in plasma thiobarbituric acid reactive substances during ACh infusion, an indicator of lipid peroxidation in coronary circulation, was higher in patients with coronary spastic angina than in control subjects (p < 0.01) but was suppressed in patients with coronary spastic angina to comparable levels in control subjects by combined infusion of vitamin C. Saline infusion had no effect.

Conclusions. The results indicate that vitamin C attenuates vasomotor dysfunction in epicardial coronary arteries in patients with coronary spastic angina. Oxygen free radicals may at least in part play a role in the abnormal coronary vasomotor reactivity in response to ACh in spasm coronary arteries.

Abbreviations and Acronyms
  ACh = acetylcholine
  ANOVA = analysis of variance
  ECG = electrocardiogram
  LAD = left anterior descending coronary artery (arteries)
  LCx = left circumflex coronary artery (arteries)
  MDA = malondialdehyde
  RCA = right coronary artery (arteries)
  TBARS = thiobarbituric acid reactive substances




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
T. Ashikaga, M. Nishizaki, H. Fujii, K. Ihara, S. Niki, T. Murai, S. Maeda, N. Yamawake, Y. Kishi, and M. Isobe
Coronary Endothelial Dysfunction and Impaired Microcirculation Response to Atrial Natriuretic Peptide in Hyperinsulinemia
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2008; 13(1): 58 - 63.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. K. Mishra
Variations in presentation and various options in management of variant angina.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 748 - 759.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. A. Kaufmann and P. G. Camici
Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications
J. Nucl. Med., January 1, 2005; 46(1): 75 - 88.
[Full Text] [PDF]


Home page
HypertensionHome page
S. Ulker, P. P. McKeown, and U. Bayraktutan
Vitamins Reverse Endothelial Dysfunction Through Regulation of eNOS and NAD(P)H Oxidase Activities
Hypertension, March 1, 2003; 41(3): 534 - 539.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Sueda, H. Kohno, H. Fukuda, K. Watanabe, N. Ochi, H. Kawada, and T. Uraoka
Limitations of Medical Therapy in Patients With Pure Coronary Spastic Angina
Chest, February 1, 2003; 123(2): 380 - 386.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Kawano, T. Motoyama, H. Yasue, N. Hirai, H. M. Waly, K. Kugiyama, and H. Ogawa
Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina
J. Am. Coll. Cardiol., July 17, 2002; 40(2): 266 - 270.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
H. Ogawa, H. Soejima, K. Takazoe, S. Miyamoto, I. Kajiwara, H. Shimomura, T. Sakamoto, M. Yoshimura, K. Kugiyama, M. Kimura, et al.
Increased Autoantibodies Against Oxidized Low-Density Lipoprotein in Coronary Circulation in Patients with Coronary Spastic Angina
Angiology, March 1, 2001; 52(3): 167 - 174.
[Abstract] [PDF]


Home page
CirculationHome page
M. M. Givertz, D. B. Sawyer, and W. S. Colucci
Antioxidants and Myocardial Contractility : Illuminating the "Dark Side" of {{beta}}-Adrenergic Receptor Activation?
Circulation, February 13, 2001; 103(6): 782 - 783.
[Full Text] [PDF]


Home page
CirculationHome page
S. Mak and G. E. Newton
Vitamin C Augments the Inotropic Response to Dobutamine in Humans With Normal Left Ventricular Function
Circulation, February 13, 2001; 103(6): 826 - 830.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kugiyama, Y. Miyao, T. Sakamoto, H. Kawano, H. Soejima, S. Miyamoto, M. Yoshimura, H. Ogawa, S. Sugiyama, and H. Yasue
Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H264 - H271.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. Kaufmann, T. Gnecchi-Ruscone, M. di Terlizzi, K. P. Schafers, T. F. Luscher, and P. G. Camici
Coronary Heart Disease in Smokers : Vitamin C Restores Coronary Microcirculatory Function
Circulation, September 12, 2000; 102(11): 1233 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Tomasian, J. F. Keaney Jr., and J. A. Vita
Antioxidants and the bioactivity of endothelium-derived nitric oxide
Cardiovasc Res, August 18, 2000; 47(3): 426 - 435.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Miyao, K. Kugiyama, H. Kawano, T. Motoyama, H. Ogawa, M. Yoshimura, T. Sakamoto, and H. Yasue
Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 432 - 437.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
O. Hirashima, H. Kawano, T. Motoyama, N. Hirai, M. Ohgushi, K. Kugiyama, H. Ogawa, and H. Yasue
Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: Possible role of reactive oxygen species
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1860 - 1866.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
B. Frei
On the Role of Vitamin C and Other Antioxidants in Atherogenesis and Vascular Dysfunction
Experimental Biology and Medicine, December 1, 1999; 222(3): 196 - 204.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
C.R. Conti
Vitamin C and coronary vasoreactivity
Eur. Heart J., November 2, 1999; 20(22): 1615 - 1617.
[PDF]


Home page
Am. J. Clin. Nutr.Home page
A. C Carr and B. Frei
Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans
Am. J. Clinical Nutrition, June 1, 1999; 69(6): 1086 - 1107.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. A. Tyurin, S.-X. Liu, Y. Y. Tyurina, N. B. Sussman, C. A. Hubel, J. M. Roberts, R. N. Taylor, and V. E. Kagan
Elevated Levels of S-Nitrosoalbumin in Preeclampsia Plasma
Circ. Res., June 8, 2001; 88(11): 1210 - 1215.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement